PDX Pharmaceuticals is an IND-enabling stage biopharmaceutical company. We develop novel combination and immunotherapies to treat cancer by bringing complementary biological pathways together to achieve synergistic clinical benefit. Our therapeutic candidates bridge the innate and adaptive immune systems by generating profound CD8+ T cell production. Our pipelines are patented AIRISE (Augmenting Immune Responses and Inhibiting the Suppressive Environment of Tumors) and ARAC (Antigen Release Agent and Checkpoint Inhibitor) pipelines that generate anti-tumor immunity when given locally (AIRISE) or systemically (ARAC) by relying on patient' s own tumor in situ as the source of antigens.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 3303 S Bond Ave, Ch13b, 13th Floor, Portland,oregon 97239,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pdxpharm.com
- HQ
- Portland, Oregon
Pdx Pharmaceuticals Questions
Pdx Pharmaceuticals's website is pdxpharm.com
Pdx Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/pdx-pharmaceuticals
Pdx Pharmaceuticals has
9 employees.
View email and phone details for 9
employees at Pdx Pharmaceuticals.
Pdx Pharmaceuticals's industry is
Biotechnology Research
Pdx Pharmaceuticals's top competitors are
Oregon Bioscience Incubator And Otradi,
Sparrow Pharmaceuticals, Inc.,
Keliomics,
Araceli Biosciences,
Trace Biosciences,
Ubivac,
Floragenex, Inc.,
Sedia Biosciences Corp.,
Oregon Bioscience Association,
Agonox, Inc..
Pdx Pharmaceuticals's categories are Biotechnology Research
Pdx Pharmaceuticals's founding year is 2010
